Latest News
February 5, 2018
Otago welcomes Simon Gwynn to the Otago team. “Simon has significant experience in working with Specialist Biopharmaceutical companies across Europe on market access and development of […]
January 5, 2018
Otago Healthcare plans participation in the 8 th Global Orphan Drug Congress in Maryland between April 24th -28th . “We believe this forum will be an […]
December 5, 2017
Otago Healthcare launches new website with strategic focus on working with Specialist Biopharmaceutical companies looking to commercialise their Orphan Drugs across Europe and the Middle East. […]
August 5, 2017
Otago welcomes Kay Drake to the Otago management team. Kay will be responsible for sales and marketing with key Orphan Drugs we will be commercialising in […]
February 5, 2017
Otago to attend the 8th Annual World Orphan Drug Congress European in Barcelona.” This congress is of vital importance for showcasing our unique commercial model for […]
December 2, 2016
Otago to attend the 4th International Conference on Drug Discovery in India as their will be key stakeholders and specialist pharma attending from key strategic markets […]
May 5, 2016
Otago appoint Andrew Hasker as Finance Director. “Andrew is a very experienced FD who has extensive global experience having worked with major US based companies with […]
February 5, 2016
Otago Healthcare will attend the 9th Biopharma Asia Convention in Singapore. “ This is a new opportunity for us to share the Otago model for market […]
December 5, 2015
Otago holds strategic meetings with specialist distributor of Orphan drugs for the Middle East. “Our discussions with our new partner for the Middle East have been […]
June 1, 2015
Otago Healthcare look to participate in the 3rd Annual Congress on Rare Diseases and Orphan Drugs in San Antonio. “This is an important forum for Otago […]